Seizure Disorders
Seizure Disorders(癫痫症)
Seizure Disorders 相关产品(93)
- GC49472Methylmalonic Acid-d3CAS: 42522-59-8纯度: >99.00%
An internal standard for the quantification of methylmalonic acid
- GC497524,5-Desisopropylidene TopiramateCAS: 106881-41-8纯度: >95.00%
An inactive metabolite of topiramate
- GC49756Safinamide AcidCAS: 1160513-60-9纯度: >95.00%
A potential impurity found in commercial preparations of safinamide
- GC49782L-Phenylalanine-13C6CAS: 180268-82-0纯度: >99.00%
An internal standard for the quantification of phenylalanine
- GC4982010,11-dihydro-10,11-dihydroxy CarbamazepineCAS: 35079-97-1纯度: >95.00%
A metabolite of carbamazepine and oxcarbazepine
- GC498611-Carboxycyclohexaneacetic AcidCAS: 67950-95-2纯度: >95.00%
A potential impurity in commercial preparations of gabapentin
- GC49865γ-D-Glutamylglycine (trifluoroacetate salt)CAS: 71822-19-0纯度: >95.00%
An excitatory amino acid antagonist
- GC52020Lamotrigine-d3CAS: 1132746-94-1纯度: >99.00%
An internal standard for the quantification of lamotrigine
- GC52484Purified Ganglioside Mixture (bovine) (ammonium salt)纯度: >98.00%
A mixture of purified bovine gangliosides
- GC91946HexylHIBO (hydrobromide)纯度: >98.00%
HexylHIBO (hydrobromide)是I组代谢性谷氨酸受体(mGluRs；mGluR1α和mGluR5a的Kbs分别为140 μM和110 μM)。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49319 | Mebicar | 10095-06-4 | >98.00% | |
An anxiolytic with antiepileptic activity | ||||
| GC49472 | Methylmalonic Acid-d3 | 42522-59-8 | >99.00% | |
An internal standard for the quantification of methylmalonic acid | ||||
| GC49501 | Nirvanol | 631-07-2 | >98.00% | |
An active metabolite of mephenytoin | ||||
| GC49538 | Lamotrigine N2-oxide | 136565-76-9 | >95.00% | |
A metabolite of lamotrigine | ||||
| GC49752 | 4,5-Desisopropylidene Topiramate | 106881-41-8 | >95.00% | |
An inactive metabolite of topiramate | ||||
| GC49756 | Safinamide Acid | 1160513-60-9 | >95.00% | |
A potential impurity found in commercial preparations of safinamide | ||||
| GC49767 | CYM 2503 | 1308833-36-4 | >95.00% | |
A GAL 2 receptor positive allosteric modulator | ||||
| GC49782 | L-Phenylalanine-13C6 | 180268-82-0 | >99.00% | |
An internal standard for the quantification of phenylalanine | ||||
| GC49820 | 10,11-dihydro-10,11-dihydroxy Carbamazepine | 35079-97-1 | >95.00% | |
A metabolite of carbamazepine and oxcarbazepine | ||||
| GC49861 | 1-Carboxycyclohexaneacetic Acid | 67950-95-2 | >95.00% | |
A potential impurity in commercial preparations of gabapentin | ||||
| GC49865 | γ-D-Glutamylglycine (trifluoroacetate salt) | 71822-19-0 | >95.00% | |
An excitatory amino acid antagonist | ||||
| GC52020 | Lamotrigine-d3 | 1132746-94-1 | >99.00% | |
An internal standard for the quantification of lamotrigine | ||||
| GC52033 | S-Methyl-D-penicillamine | 29913-84-6 | >95.00% | |
A metabolite of D-penicillamine | ||||
| GC52473 | NVP-AAM077 | 2514919-70-9 | >95.00% | |
An NMDA receptor antagonist | ||||
| GC52484 | Purified Ganglioside Mixture (bovine) (ammonium salt) | - | >98.00% | |
A mixture of purified bovine gangliosides | ||||
| GC52496 | Sulfatide (bovine) (sodium salt) | - | >95.00% | |
A mixture of isolated bovine sulfatides | ||||
| GC90480 | Safinamide Metabolite NW 1689 | 405-85-6 | >95.00% | |
商业制备的沙非胺中发现了潜在杂质。 | ||||
| GC90597 | LY2365109 (hydrochloride) | 1779796-27-8 | >95.00% | |
一种GlyT1a抑制剂 | ||||
| GC91153 | Sulfonadyn-47 | - | >98.00% | |
一种动力蛋白抑制剂 | ||||
| GC91906 | (R)-AS-1 | 2506367-95-7 | >95.00% | |
(R)-AS-1是兴奋性氨基酸转运蛋白2 EAAT2的正变构调节剂；谷氨酸摄取试验中的EC50=11nM。 | ||||
| GC91946 | HexylHIBO (hydrobromide) | - | >98.00% | |
HexylHIBO (hydrobromide)是I组代谢性谷氨酸受体(mGluRs；mGluR1α和mGluR5a的Kbs分别为140 μM和110 μM)。 | ||||